Bianca Jean LaCaille

Representative Transactions:

• Morgan Stanley, J.P. Morgan, Wells Fargo Securities, BofA Securities, Capital One Securities and CIBC Capital Markets as underwriters in the US$251 million IPO for FrontView REIT, Inc (NYSE: FVR)
• Skyward Specialty Insurance Corporation (NASDAQ: SKWD) in its US$134 million IPO and US $102 million secondary offering
• ON24 Inc. (NYSE: ONTF) in its US$492 million IPO
• Adaptive Biotechnologies Corporation (NASDAQ: ADPT) in its US$345 million IPO, US$244 million secondary offering and US$368 million follow-on offering (including $80 million secondary)
• Akoya Biosciences Inc. (NASDAQ: AKYA) in its US $151 million IPO, in the establishment of its US$50 million at-the-market equity program and US$47.8 million follow-on offering
• Cowen and Company, LLC, William Blair & Company, BTIG, LLC and Stephens Inc. as underwriters in the US$110.4 million IPO for Alpha Teknova, Inc. (NASDAQ: TKNO)
• Needham & Co., Canaccord Genuity and Raymond James as underwriters in the US$60 million IPO for Absolute Software Corporation (NASDAQ: ABST, TSX: ABST)
• TD Securities (USA) LLC, William Blair & Company, L.L.C., BTIG, LLC and Lake Street Capital Markets, LLC as underwriters in the US$40 million follow-on offering for MDxHealth SA (NASDAQ: MDXH)
• Cowen and Company, LLC and William Blair & Company, L.L.C. as underwriters in the US$43 million offering of American Depositary Shares of MDxHealth SA (NASDAQ and Euronext Brussels: MDXH)
• Piper Sandler & Co. and Oppenheimer & Co. as underwriters in the US$45 million IPO for MDxHealth SA (NASDAQ and Euronext Brussels: MDXH)
• Bsquare Corporation (NASDAQ: BSQR) in the establishment of its $25 million at-the-market equity program
• HEXO Corp. (NASDAQ: HEXO, TSX: HEXO) in its offering of US$360 million of senior secured convertible notes, US$44 million shelf takedown, US$40.4 million offering and US$57.5 million offering
• Piper Sandler & Co. as underwriter in the US$92 million common stock offering by Infinity Pharmaceuticals (NASDAQ: INFI)
• The Agents in GoldMining Inc.’s (NYSE American: GOLD, TSX: GLDG) US$50 million at-the-market equity program
• The Agents in Uranium Royalty Corp’s (NASDAQ: UROY, TSXV: URC) US$40 million at-the-market equity ‎program
• The Agents in Dakota Gold Corp’s (NYSE American: DC) US$50 million at-the-market equity program
• The Agents in Gold Royalty Corp’s (NYSE American: GROY) US$50 million at-the-market equity program
• Founder, CEO and controlling shareholder as the buyer of a publicly traded technology company in a go-private transaction

Representative Public Reporting ’34 Act Clients:

• Adaptive Biotechnologies Corporation (NASDAQ: ADPT)
• Skyward Specialty Insurance Corporation (NASDAQ: SKWD)
• Hagerty Inc. (NYSE: HGTY)
• Trupanion Inc. (NASDAQ: TRUP)
• ON24 Inc. (NYSE: ONTF)
• Akoya Biosciences Inc. (NASDAQ: AKYA)
• Bsquare Corporation (NASDAQ: BSQR)
• Xperi Inc. (NYSE: XPER)